NEWS

News Articles

Georgia Tech’s Paul Joseph Awarded Fulbright Specialist Grant to India

May 4, 2022

Paul Joseph, a principal research scientist in the Institute for Electronics and Nanotechnology (IEN) at Georgia Tech, has received a Fulbright Specialist Award to India from the Fulbright Foreign Scholarship Board. Joseph will spend two weeks at the Indian Institute of Information technology (IIIT) this summer helping to expand the nanotechnology curriculum and assisting with…

Read More

Saol Therapeutics Announces First Patient Dosed in Phase 2 RAISE Spasticity Trial Evaluating the Safety Profile of SL-1002 for Limb Spasticity

May 4, 2022

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the first patient has been enrolled in the company’s Phase 2 RAISE Spasticity Trial.  SL-1002 is a novel, proprietary, nerve-blocking agent currently under development at Saol Therapeutics and is being evaluated in the RAISE Spasticity Trial.  The trial is a double-blind, placebo-controlled, single ascending-dose…

Read More

Missing our great physicist Sérgio Mascarenhas, defender of science

April 29, 2022

The passing of the scientist, physicist and chemist was mourned by all those who believe in scientific development, democratization of education and science as a way to build a fairer society in Brazil, with more health and access to all. Professor at the Institute of Physics of São Carlos, University of São Paulo, and honorary…

Read More

BioMarin Pharmaceutical commemorates 5 years of helping children with fatal rare disease

April 29, 2022

CLN2 Batten disease is a rare, inherited, fatal disorder that primarily affects the nervous system as a result of a failure to produce enough of the enzyme TPP1. The signs and symptoms of this condition typically start between the ages of 2 and 4, featuring recurrent seizures and coordination difficulty. BioMarin Pharmaceutical in San Rafael…

Read More

Saol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease

April 28, 2022

Program Discusses Access to a Pivotal Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency (DCA/PDCD trial; NCT02616484) Saol Therapeutics, a company researching new treatments for rare diseases, is pleased to announce a partnership with InformedDNA®, the nation’s leading applied genomics solutions company, to offer genetic counseling for the families of individuals with a…

Read More

Georgia Bio Names South Forsyth High School Junior as 2022 Georgia BioGENEius Winner

April 14, 2022

Mokshith Mannuru Advances to International Competition Against Top Students Georgia Bio and the BioEd Institute named Mokshith Mannuru, a junior at South Forsyth High School in Cumming, GA, as the winner of the 2022 Georgia BioGENEius Challenge. The BioGENEius Challenge is the premier competition for high school students that recognizes outstanding research and innovation in the…

Read More